Dysregulated rRNA synthesis by RNA polymerase I (Pol I) is associated with uncontrolled cell proliferation. Here, we report a box H/ACA small nucleolar RNA (snoRNA)-ended long noncoding RNA (lncRNA) that enhances pre-rRNA transcription (SLERT). SLERT requires box H/ACA snoRNAs at both ends for its biogenesis and translocation to the nucleolus. Deletion of SLERT impairs pre-rRNA transcription and rRNA production, leading to decreased tumorigenesis. Mechanistically, SLERT interacts with DEAD-box RNA helicase DDX21 via a 143-nt non-snoRNA sequence. Super-resolution images reveal that DDX21 forms ring-shaped structures surrounding multiple Pol I complexes and suppresses pre-rRNA transcription. Binding by SLERT allosterically alters individual DDX21 molecules, loosens the DDX21 ring, and evicts DDX21 suppression on Pol I transcription. Together, our results reveal an important control of ribosome biogenesis by SLERT lncRNA and its regulatory role in DDX21 ring-shaped arrangements acting on Pol I complexes.
INTRODUCTION
Long noncoding RNAs (lncRNAs) are important modulators of nuclear organization and function. They are responsible for nuclear structure integrity and can regulate the expression of either nearby genes or of genes elsewhere in cells via multiple mechanisms, including through recruiting transcription factors or chromatin-modifying complexes to their DNA targets, by forming ribonucleoprotein complexes, by acting as decoys to sequester RNA binding proteins, or by directly interacting with RNAs and DNAs by base-pairing (Chen, 2016) .
The nucleolus is a non-membrane-bound nuclear organelle found in all eukaryotes and best known for its role in coordinating ribosome biogenesis. Nucleoli form around specific chromosomal features called nucleolar organizing regions (NORs) that contain arrays of rDNAs. In the human genome, there are >400 copies of rDNAs with interspersed active and inactive gene repeats distributed along five chromosomes, and only some rDNA genes remain active (Boisvert et al., 2007) . How specific rDNA genes within a NOR cluster remain transcriptionally inert is unclear. The active rDNAs are transcribed by RNA polymerase I (Pol I) to produce pre-rRNAs that undergo modification and processing to remove external transcribed spacers (ETSs) and internal transcribed spacers (ITSs) to yield mature 18S, 5.8S, and 28S rRNAs (McStay, 2016) . Pol I activity is a key determinant for the level of ribosome production and controls cell growth and proliferation. Uncontrolled rRNA synthesis by Pol I is associated with aberrant cell proliferation (Nguyen et al., 2015; Peltonen et al., 2014) .
Although lncRNAs are suspected to impact many cellular processes, few have been reported to be involved in nucleolar functions or Pol I transcription regulation. In mouse cells, two rDNAproduced lncRNAs were shown to regulate rRNA synthesis at the chromatin level (Schmitz et al., 2010; Bierhoff et al., 2014) . The promoter-associated RNAs (pRNAs) are produced from rDNA promoters and can trigger DNA methylation and silence rRNA genes depending on the nucleolar remodeling complex (Schmitz et al., 2010) . The Papas (promoter and pre-rRNA antisense) lncRNA triggers H4K20me3 at rDNAs by binding the H4K20 methyltransferase Suv4-20h2 to silence rDNAs in quiescent cells (Bierhoff et al., 2014) . However, whether pRNA and Papas play similar roles in human and whether the Pol I activity is controlled by regulatory RNAs are unknown.
While a large proportion of lncRNAs look like mRNAs, a number of lncRNAs are processed in unusual ways (Chen, 2016) . The excised intron-derived sno-lncRNAs are formed when one intron contains two small nucleolar RNA (snoRNA) genes (Yin et al., 2012) . After splicing, the sequences between the snoRNAs are not degraded, leading to the accumulation of lncRNAs flanked by snoRNA sequences but lacking 5 0 caps and 3 0 poly (A) tails. Both box C/D and box H/ACA snoRNA-ended lncRNAs are expressed in mammals and their expression is associated with alternative splicing (Zhang et al., 2014) . Here, we report the biogenesis and function of a box H/ACA snoRNA-ended snolncRNA, referred to SLERT (snoRNA-ended lncRNA enhances pre-ribosomal RNA transcription). SLERT is different from reported Prader-Willi Syndrome (PWS) sno-lncRNAs and plays a crucial role in rRNA biogenesis by dislodging a previously unknown clamp of DDX21 ring-shaped arrangements on Pol I complexes, thereby liberating Pol I for active rRNA transcription.
RESULTS
Box H/ACA snoRNAs Are Required for SLERT lncRNA Formation and Nucleolar Localization Non-polyadenylated (non-poly(A)) RNA sequencing (RNA-seq) (Yang et al., 2011) allowed us to identify sno-lncRNAs (Yin et al., 2012; Zhang et al., 2014) . One box H/ACA snoRNA-ended lncRNA, SLERT, is robustly expressed in human embryonic stem cells (hESCs) H9 and ovarian carcinoma cells PA1 with $210 or 156 copies per cell, respectively (Figures 1A, S1A, and S1B). It is also highly expressed in many other examined human cell lines ( Figure S1C ).
SLERT is 694 nt in length and contains SNORA5A and SNORA5C at its ends ( Figure 1A ). It is produced from the human TBRG4 locus via skipping of exons 4 and 5 ( Figure 1B ) that leads to both SNORA5A and SNORA5C embedded within one intron, thereby producing SLERT from this large and alternatively spliced intron ( Figure 1C ). The shorter isoform of TBRG4 with skipped exons could be detected in PA1 cells ( Figure S1D ) with a relatively rapid degradation rate ( Figure S1E ). Thus, at the TBRG4 locus, alternative splicing of the TBRG4 pre-mRNA produces either TBRG4 and two individual snoRNAs or SLERT and an alternatively spliced TBRG4 isoform with exons 4 and 5 skipped ( Figure 1C ). The unusual processing of SLERT indicates that its expression regulation may occur at multiple levels.
DKC1 is one key component of the box H/ACA snoRNP (Watkins and Bohnsack, 2012) . SLERT could be efficiently immunoprecipitated with anti-DKC1 antibodies, while control RNAs including a box C/D snoRNA-ended lncRNA or XIST, could not ( Figure S1F ), supporting the notion that SLERT is ended with box H/ACA snoRNPs. To dissect the mechanism of SLERT processing, we constructed a set of SLERT mutant vectors in which the loops or the box H motifs of the two snoRNA ends were sequentially deleted ( Figure 1D ). These plasmids were individually transfected to HeLa cells, which have the relatively low level of endogenous SLERT ( Figure S1C ), followed by northern blotting (NB) to detect SLERT processed from each mutant. Results clearly showed that both H motifs and two outside loops of both box H/ACA snoRNAs were crucial for SLERT processing (Figure 1D, 1, 2, 6 , and 7), while effects of deleting inside loops were minor on SLERT formation ( Figure 1D , 3 and 5). Furthermore, deletion of the box ACA motif at the 3 0 end of SLERT (Figure 1D, 8) , but not the one within SLERT ( Figure 1D , 4), impaired its processing. Thus, SLERT processing requires essential motifs of each box H/ACA snoRNA at its end that is able to form the intact or partial snoRNP complex. Such H/ACA snoRNPs at the ends protect the intronic sequence from exonuclease trimming after splicing, leading to SLERT formation.
It is becoming increasingly clear that the function of lncRNAs is associated with their unique subcellular localization patterns (Chen, 2016) . Subcellular fractionation followed by RT-PCR in PA1 cells revealed that SLERT mainly accumulated in the nucleolus ( Figure 1E ). Co-staining of SLERT by RNA fluorescence in situ hybridization (FISH) and the nucleolar marker protein nucleolin showed that SLERT almost exclusively localized to nucleoli in PA1 ( Figure 1F ), CRL-5807, and H9 cells ( Figure S1G ) that have high SLERT levels ( Figure S1C ). Of note, its nucleolar localization could also be detected in HeLa cells that have relatively low SLERT expression ( Figure S1G) .
Interestingly, the TBRG4 gene locus, from which SLERT is generated, is located at a distance from nucleoli in cells (Figure 1G) . This observation indicates that a specific mechanism is associated with SLERT translocation to the nucleolus. It is known that most snoRNAs localize to the nucleolus or traffic through the nucleolus during their life cycles (Boisvert et al., 2007) ; thus, it is tempting to speculate that snoRNAs at the ends of SLERT are required for its nucleolar translocation. We constructed three vectors that expressed wild-type (WT) or mutants of SLERT (WT-SLERT MUT and egfp-SLERT) ( Figure 1H ). The WT-SLERT MUT contains deletion of the two inside loops of snoRNAs so that a mutant SLERT carrying the full internal sequence, but without intact snoRNA ends, was generated. In the egfp-SLERT mutant, the internal sequence of SLERT was replaced with a fragment of egfp so that a mutant egfp-SLERT was produced with intact snoRNA ends and an egfp insertion ( Figure 1H ). Transfection of each plasmid, followed by detection of SLERT RNA and nucleolin, showed that egfp-SLERT mainly localized to the nucleolus while the WT-SLERT MUT largely distributed in the nucleoplasm ( Figure 1H ). These results support the view that SLERT requires its box H/ACA snoRNA ends for translocation to the nucleolus.
SLERT Promotes Pre-rRNA Transcription via Its Non-snoRNA Region in the Nucleolus Because SLERT mainly accumulates to the nucleolus, we asked whether SLERT would have any measurable effect on rRNA biogenesis. We generated SLERT knockout (KO) PA1 cells by CRISPR/CAS9 without affecting its parental TBRG4 mRNA expression. To do so, we designed two single-guide RNAs (sgRNAs) that individually target the minimal sequence that is required for SLERT formation, the box H of each snoRNA (Figures 1D and 2A) . A number of clones were obtained with disrupted SLERT expression (Figures S1H and S1I), and two clones were used in this study (Figures 2A and 2B) . As expected, TBRG4 protein levels were not affected in these SLERT KO cells ( Figure 2C ), excluding potential roles that TBRG4 may play in the observable SLERT phenotypes. It should be noted that one of the two snoRNAs was also depleted in each corresponding SLERT KO single clone ( Figure 2B ). In these SLERT KO cell lines, steady-state levels of 47S pre-rRNA were remarkably reduced ( Figure 2D ). Similar results were also observed in other SLERT KO cell lines ( Figure S1I ). In addition, SLERT depletion resulted in decreased 28S and 18S rRNAs by comparing RNAs collected from an equal number of cells in control and SLERT KO cells ( Figures 2B and 2D ). The reduction of mature rRNAs was further evidenced by decreased 40S and 60S ribosomal subunits extracted from SLERT KO cells ( Figure 2E ), confirming an important role of SLERT in rRNA biogenesis. rRNA production results from both rRNA transcription and processing. To dissect at which level SLERT regulates prerRNA abundance, we set up assays to discriminate 47S prerRNA transcription from its processing. We treated PA1 cells with 5-fluorouracil (5-FU) to stop pre-rRNA processing (Zhang et al., 2011) and then pulse-chased with 4-thiouridine (4sU) to detect nascent pre-rRNA in control and SLERT-depleted cells . Nascent pre-rRNA was dramatically (B) Recapitulation of SLERT processing. Top: a schematic drawing of SLERT and its flanking sequences cloned into pcDNA3 for SLERT expression; 1 includes exons 3-6, whereas 2 includes exons 3-5 of TBRG4 and their flanking introns containing SLERT. Bottom: SLERT formation requires exon skipping of exons 4 and 5 of TBRG4 shown by NB. Equal amount of total RNA isolated from HeLa cells transfected with each indicated plasmid was resolved on agarose gels for NB with an antisense probe (black bar). Note that the NB probe for SLERT also recognizes exon 4 of TBRG4 mRNA and both spliced linear mRNAs and SLERT could be detected. M, RNA marker; EV, empty vector. See also Figure S1D . (C) A schematic view of SLERT processing. See also Figure S1E . (D) SLERT processing requires intact H/ACA boxes at both ends. Left: a schematic drawing of wild-type (WT) SLERT (clone 1 in B) and deletions of box H/ACA (clones 1-8, red dashed lines). Right: NB of SLERT clones expressed in HeLa cells. NT, no transfection. See also Figure S1F . (E) SLERT accumulates to the nucleolus. Total RNA from PA1 cells was separated into cytoplasmic, nuclear, nucleoplasmic, and nucleolar fractions and analyzed by semiquantitative RT-PCR. (F) SLERT localizes to the nucleolus. Co-staining of SLERT (green) and nucleolin (red) in PA1 cells. See also Figure S1G .
(G) The TBRG4 locus localizes at a distance to the nucleolus, revealed by double FISH in PA1 cells. Green, pre-rRNA; red, TBRG4 DNA locus. (H) SLERT requires its box H/ACA snoRNA ends to translocate to the nucleolus. HeLa cells were transfected with each indicated plasmid, followed by co-staining of WT-SLERT, WT-SLERT MUT , or egfp-SLERT (green) and nucleolin (red). Probes for WT-SLERT and WT-SLERT MUT are shown in (B) and egfp-SLERT is shown as a green bar. See also Figure S1G . Figure 1D ). Control PA1 cells (Ctrl.), transfected PX330 empty vector. Two single clones carrying the indicated deletion are used in this study. See also Figures S1H and S1I. (B) SLERT KO leads to reduced 28S and 18S rRNAs in PA1 cells. Total RNA collected from equal number of cells across samples was loaded for NB, and actin mRNA was used as a control. See also Figure S1J . (C) SLERT KO by CRISPR/CAS9 has no detectable effect on TBRG4, revealed by WB. (D) SLERT KO reduces the steady-state level of pre-rRNA, revealed by qRT-PCR (left) and NB (right). For qRT-PCR, data were normalized to actin. For NB, total RNA collected from equal number of cells across samples was loaded. Primers and NB probe recognize human rDNA sequences from +307 to +442 that map uniquely to 47S pre-rRNA (Feng et al., 2010) . See also Figure S1I . (E) SLERT KO impairs rRNA biogenesis. Cell lysates from control and SLERT KO cells were separated from gradient 10% to 45% sucrose density and measured absorbance under 254 nm UV light. Three major absorption peaks represent 40S, 60S ribosomal subunit, and 80S ribosome.
(F) Nascent pre-rRNA transcription is decreased in SLERT KO cells. SLERT KO cells were pretreated with 5-FU for 3 hr to stop pre-rRNA processing and 4sU labeling in the last 0.5 hr, followed by collection of nascent pre-rRNA for qRT-PCR, normalized to nascent actin pre-mRNA. (G) Luciferase reporter assay of rDNA promoter in SLERT KO cells. The rDNA promoter and an IRES sequence were cloned upstream of the promoter-less Firefly luciferase coding region. Data were normalized to Renilla luciferase and presented with respect to control cells set to a value of 1. (H) The internal sequence of SLERT promotes pre-rRNA transcription. Left: qRT-PCR revealed the relative level of WT-and egfp-SLERT in SLERT KO cells (normalized to actin mRNA). Right: OE of WT-, but not egfp-SLERT, in SLERT KO cells rescued pre-rRNA production. For NB, total RNA collected from equal number of cells across samples was loaded. See also Figure S1J . In (D) and (F)-(H), error bars represent SD in triplicate experiments. *p < 0.05 and **p < 0.01 (Student's t test).
decreased in SLERT KO cells compared to that in control cells ( Figure 2F ), suggesting that SLERT regulation largely occurs at the transcriptional level. In agreement with this result, the luciferase reporter assay of the rDNA promoter also showed marked decreases of luciferase in SLERT KO cells ( Figure 2G ). In addition, overexpression (OE) of WT-SLERT, but not egfp-SLERT mutant ( Figure 1H ), enhanced pre-rRNA expression ( Figure S1J ). Similarly, WT-SLERT, but not egfp-SLERT OE in SLERT KO cells, rescued pre-rRNA production ( Figure 2H ). Together, these results suggest that the internal region of SLERT is essential for promoting rRNA transcription, and SLERT is capable of interfering with Pol I transcription via its non-snoRNA sequence.
The Non-snoRNA Internal Sequence of SLERT Interacts with DDX21 in the Nucleolus To gain insight into the mechanism of SLERT-enhanced rRNA transcription, we fused the tRNA scaffold to a Streptavidin aptamer (tRSA) (Iioka et al., 2011) with the full-length SLERT (tRSA-SLERT) to identify SLERT-associated proteins ( Figure 3A ). tRSA-SLERT or tRSA alone was incubated with PA1 cell lysates, and tRSA-SLERT-enriched bands were subjected to mass spectrometry (MS) ( Figures 3B and S2A ). Among identified proteins by MS, one specific one was DDX21 ( Figure 3B ). Reciprocal immunoprecipitation using DDX21 antibodies to detect its associated RNAs under both native and formaldehyde cross-linking conditions confirmed that DDX21 interacted with SLERT ( Figure 3C ). Immunofluorescence (IF) images also showed the colocalization of DDX21 and SLERT in the nucleolus ( Figure 3D ). Interestingly, some other proteins (e.g., hnRNP U) were also found to affect rRNA biogenesis ( Figures S2B and S2C) ; however, they non-specifically bound to both tRSA-SLERT and tRSA ( Figure 3B ), and they were also not located to the nucleolus ( Figures S2B and  S2C ), thus they were excluded from further analyses. DDX21 is a DEAD-box RNA helicase and known to be involved in multiple steps of ribosome biogenesis (Calo et al., 2015; Holmströ m et al., 2008; Sloan et al., 2015) . We asked how SLERT interacts with DDX21. First, we found that the full-length and the internal non-snoRNA sequence of SLERT showed comparable binding affinity to DDX21 ( Figure 3E ). We then made a series of SLERT fragments to dissect the binding capacity of different regions of SLERT with DDX21. Each digoxin (Dig)-labeled SLERT fragment was incubated with the partially purified DDX21, and eluted RNAs were resolved on denaturing PAGE gel followed by immunoblotting with anti-Dig antibodies. We found that the internal sequence exhibited similar binding capability to fulllength SLERT ( Figure 3F , lanes 1 and 2), confirming results obtained from tRSA precipitation assays ( Figure 3E ). Importantly, we identified a 143-nt fragment located in the 3 0 region of SLERT (SLERT 143 ) to specifically interact with DDX21 ( Figure 3 , lane 9), whereas SNORA5C and SNORA5A exhibited, at best, limited binding to DDX21 ( Figure 3F, lanes 3 and 4) . Further splitting the 143-nt sequence to smaller fragments eliminated DDX21 binding ( Figure 3F , lanes 10 and 11), indicating that this 143-nt sequence may fold into a higher order structure that is required for DDX21 binding. To further test the interaction between SLERT and DDX21, we conducted electrophoretic mobility shift assays (EMSAs) between in vitro transcribed (IVT) SLERT 143 and purified His-DDX21 ( Figure S2D ). As expected, EMSAs revealed a direct interaction between DDX21 and SLERT 143 . SLERT 143 could bind to multimeric DDX21 when the protein was at high concentrations ( Figure 3G ). These analyses reveal that the non-snoRNA region of SLERT directly interacts with DDX21, consistent with the notion that the internal sequence of SLERT is responsible for promoting rRNA transcription (Figure 2) , and snoRNA ends are required for nucleolar translocation ( Figure 1H ).
DDX21 Forms Ring-Shaped Arrangements
To decipher the function of DDX21 in the nucleolus, we examined DDX21 subcellular localization in great detail. Standard IF of DDX21 and nucleolin in fixed PA1 cells visualized by wide-field microscopy revealed that DDX21 was co-localized with nucleolin and enriched in the nucleolus ( Figure 4A ). Fusion of EGFP to the N terminus of DDX21 and imaging EGFP-DDX21 in live cells also revealed a remarkable nucleolar accumulation of DDX21 (Figure S3A) . Importantly, application of super-resolution structured illumination microscopy (SIM) unexpectedly revealed a striking organization pattern of DDX21 in the nucleolus: all detectable DDX21 forms donut-like ring structures with diameters at $400 nm ( Figure 4B ; Movie S1). On average, 60 DDX21 rings per cell were observed in fixed PA1 cells ( Figure 4C ). To exclude artifacts that might be caused by antibodies or fixation conditions, we also visualized DDX21 localization in live cells. Using a live-cell deconvolution imaging system (lateral resolution $250 nm), we observed that both N-terminal fused EGFP-DDX21 and C-terminal fused DDX21-mCherry exhibited donutlike arrangements in the nucleolus in live PA1 (Figures S3B and S3C; Movie S2) and HeLa ( Figure S3D ) cells. Together, these observations reveal that DDX21 is mainly located to the nucleolus and forms specific spatial arrangements. DDX21 Ring-Shaped Arrangements Surround Pol I and Suppress Pol I Transcription To dissect how DDX21 and its ring-like arrangements act in the nucleolus, we treated PA1 cells with actinomycin D (AMD) or 5-FU to inhibit rRNA transcription or processing, respectively. The ring pattern of DDX21 was completely disrupted when Pol I transcription was repressed by different concentrations of AMD for 3 hr (50 ng/mL, Figure 4D ; 1 mg/mL and 10 mg/mL, Figure S3E ). In contrast, no detectable effect by SIM could be observed when pre-rRNA processing was blocked ( Figure 4D ). The disruption of DDX21 ring-like structures was also observed in live cells expressing EGFP-DDX21 after 50 ng/mL AMD treatment ( Figure S3F ). These results reveal that the DDX21 ringshaped arrangements are coupled to rRNA transcription but not to pre-rRNA processing.
These observations ( Figures 4D, S3E , and S3F) prompted us to examine the detailed spatial relationship between DDX21 rings and Pol I complexes. SIM observations of DDX21 and RPA194, the largest subunit of the Pol I complex, revealed a striking localization pattern between these two proteins: almost all detectable RPA194 is located in the halo center of DDX21 rings ( Figure 4E ). Inhibition of Pol I transcription by AMD completely impaired DDX21 ring-shaped arrangements surrounding Pol I complexes ( Figure 4D ). Live cell imaging also confirmed the unique localization pattern between DDX21 and RPA194 in PA1 ( Figure 4F ; Movie S3) and HeLa ( Figure S3G ) cells. Moreover, the same localization between DDX21 and another subunit of the Pol I complex, RPA49, was found in PA1 ( Figure 4G ) and HeLa ( Figure S3H ) cells. Finally, similar observations were observed in examined HEK293 and SH-SY5Y cell lines ( Figure S3I ).
The remarkable DDX21 and Pol I arrangement suggests that DDX21 plays an important role in Pol I transcription. In Figure S3J ). Similar ChIP results were also reported (Calo et al., 2015) . Further coimmunoprecipitation (coIP) showed the interaction between DDX21 and RPA194 ( Figure 4H ). Knockdown of DDX21 in PA1 cells by two different short hairpin RNAs (shRNAs) ( Figure 4I ) led to both increased steady-state ( Figure 4J ) and nascent (Figure 4K ) levels of 47S pre-rRNA. Meanwhile, we observed increased Pol I engagements to the promoter and 28S/18S regions, but not to IGS sequences of rDNA clusters ( Figure 4L ), indicating that DDX21 suppresses rDNA transcription by preventing Pol I loading to rDNAs. Together, these results suggest that the DDX21 ring-like structures are associated with suppressed pre-rRNA transcription.
DDX21 Ring Structures Assemble at the Border between FC and DFC and Their Sizes Correlate with Pre-rRNA Production
The nucleolus can be divided into three subregions, fibrillar center (FC), dense fibrillar component (DFC), and granular compartment (GC). Transcription of rDNA repeats occurs mainly at the border between FC and DFC with Pol I subunits being enriched in the FC region. The processing and modification of pre-rRNA transcripts occurs largely in DFC where the snoRNPs accumulate (Boisvert et al., 2007) . Co-localization studies revealed that DDX21 largely overlapped with the DFC marker fibrillarin, but not the GC marker B23 (Figures S4A and S4B) . Together with the observation that DDX21 rings coat Pol I complexes (Figures 4 and S4C) , all findings support the view that DDX21 rings are assembled at the border between FC and DFC, where the transcription of rDNA repeats occurs in active NORs. Further co-localization studies among DDX21, RPA194, and rDNAs showed that rDNAs were engaged to multiple Pol I complexes surrounded by individual DDX21 rings ( Figures 5A and S4D ). Of note, the ring structures were somewhat impaired by the harsh denatured condition during FISH procedure. Also, we found that not all rDNAs were co-localized with DDX21 ( Figure S4E ), further indicating that DDX21 rings only associate with actively transcribed NORs ( Figures 4D-4G and 5A). The transcription-dependent ring-shaped structures surrounding Pol I complexes ( Figure 4 ) and their specific subnucleolar localization (Figures 5A and S4A-S4D) let us ask how DDX21 rings affected pre-rRNA synthesis at active NORs. We used RNA FISH, with a probe recognizing 47S pre-rRNA, to examine prerRNA produced from each DDX21 ring by measuring the relative pre-rRNA fluorescence intensity that coats the ring ( Figure S5A ). Strikingly, all detectable DDX21 ring-like structures were coated by pre-rRNAs, and all detectable pre-rRNAs were associated with the ring structures ( Figure 5B ). The fluorescence intensity of pre-rRNA coated on an individual DDX21 ring was positively correlated with the diameter of each corresponding ring structure ( Figure 5C ), indicating that the enlarged DDX21 rings are correlated with augmented pre-rRNA transcription, although DDX21 rings alone act to suppress Pol I transcription ( Figures  4H-4L ). (Figure 3 ), we then examined the spatial localization of SLERT, DDX21, and Pol I under SIM. Co-visualization among these three factors revealed that SLERT was located to DDX21 rings, but not Pol I ( Figure 5D ). We observed that one to several SLERT spots were specifically co-localized to DDX21 rings ( Figure 5E ), but almost no-colocalization between SLERT and Pol I was found. These observations strongly suggest that SLERT enhances Pol I transcription via DDX21 rings.
How do DDX21 and SLERT act together to carry out their distinct roles in rRNA biogenesis? One possibility was that depletion of SLERT might reduce DDX21 expression, which in turn inhibited . However, expression of both DDX21 and RPA194 was not altered in SLERT KO, excluding this gene expression regulatory loop model ( Figure S4F ).
Another possibility was that SLERT could alter the conformation of DDX21 rings coating Pol I complexes, resulting in enhanced pre-rRNA production. SIM observations of DDX21 and RPA194 in PA1 cells that were depleted or overexpressed SLERT indeed showed remarkable differences regarding the size of DDX21 rings (Figures 5F, top panel, and S6). SLERT KO consistently reduced DDX21 ring sizes, with diameters from an average of $395 nm (394.8 ± 84.59 nm) in wild-type PA1 cells to an average of $360 nm in two SLERT KO cell lines (KO-1, 364.4 ± 76.75 nm; KO-2, 357.8 ± 75.69 nm) (Figures 5F and S6A-S6C), whereas OE SLERT in SLERT KO cell lines could not only rescue but also enlarge DDX21 rings to $420 nm compared to those in wild-type cells (KO-1 + SLERT OE, 423.6 ± 99.26 nm; KO-2 + SLERT OE, 417.8 ± 90.76 nm; WT + SLERT OE, 413.6 ± 90.3 nm; Figures 5F and S6D-S6F). Of note, the abundance of overexpressed SLERT is $25-to 40-fold of its endogenous level in wild-type cells ( Figure 5F , middle panel). Correspondingly, pre-rRNA production was also reduced or increased in SLERT KO or OE cells ( Figure 5F , bottom panel).
We then examined the localization pattern between SLERT and DDX21 rings in SLERT OE cells. We expected to see a more evenly distributed SLERT overlapping with individual rings because its copy numbers were significantly increased from $156 ( Figure S1A ) to 4,000-6,000 ( Figure 5F ) per cell in the nucleolus. Surprisingly, however, we observed a similar pattern between SLERT and these ring-shaped arrangements in SLERT OE and WT cells (Figures 5E and S4G) : only one to several SLERT spots were specifically co-localized to DDX21 rings (Figure 5E) . This observation suggests that SLERT does not randomly interact with the ring but prefers to bind specific places of each ring-like structure. Remarkably, although the co-localization pattern between SLERT and DDX21 rings remained unchanged, the fluorescence intensity of SLERT coating per ring was increased in SLERT OE cells ( Figure 5G ). Further analyzing SLERT integrated fluorescence intensities associated with individual DDX21 rings and the ring's diameter revealed their positive correlation in a power function distribution (Figures 5G and S5B) . Thus, although SLERT positively controls the size of DDX21 ring-shaped structures within a certain range, the rings cannot reach unlimited size for Pol I transcription regulation no matter how many additional SLERT lncRNAs are introduced into cells. These results indicate a tight regulation of DDX21 rings on Pol I transcription.
The conformational change of DDX21 rings regulated by SLERT ( Figure 5 ) led us to speculate that binding by SLERT would allosterically change individual DDX21 molecules, which could occur where SLERT binds within each ring. To test this hypothesis, we developed a Fö rster resonance energy transfer (FRET) assay to examine the conformational change of individual DDX21 molecules in the presence and absence of SLERT. We fused EGFP to the N-terminal end of DDX21 and mCherry to the C-terminal end of DDX21 (EGFP-DDX21-mCherry). FRET would occur only when N-and C-terminal domains of DDX21 were in close proximity (<10 nm) ( Figure 6A , left panel). We found that the FRET efficiency of EGFP-DDX21-mCherry in each of two SLERT KO cells was consistently decreased compared to that in normal cells ( Figure 6A , right panel), suggesting that more ''open'' conformational change between N-and C-terminals of DDX21 could occur in the absence of SLERT ( Figure 6A ). As controls, no change of inter-molecular interaction between C-terminal mCherry-fused DDX21 and N-terminal EGFP-fused DDX21 could be detected by FRET in wild-type or SLERT KO cells ( Figure 6B ).
Modulation of DDX21 by SLERT Alters Its Binding to Pol I and the Pol I Occupancy at rDNAs
To investigate the effect of SLERT binding on DDX21, we mapped how DDX21 interacted with SLERT and Pol I in the nucleolus. DDX21 has N-and C-terminal domains and two conserved RecA domains (D1 and D2 for short) involved in ATP binding and hydrolysis (Bourgeois et al., 2016) . Application of NoD, a web server that has been used to predict nucleolar localization sequence (NoLS) (Scott et al., 2011) , revealed that DDX21 contains NoLSs located in its N-and C-terminal domains (Figure S7A) . This was further confirmed by the observation that DDX21 lacking the N-or the C-terminal domain was no longer localized to the nucleolus, and DDX21 lacking the D1 or the D2 domain was still enriched in the nucleolus ( Figure S7B ). We next generated a series of DDX21 truncations carrying both Nand C-terminal NoLSs to ensure all expressed DDX21 mutants were located in the nucleolus ( Figure S7C ). PA1 cells transfected with individual Flag-tagged DDX21 truncations ( Figure 6C ) were precipitated by anti-Flag antibodies, followed by the detection of each Flag-DDX21-truncation-associated RPA194 ( Figure 6D , upper panels) or by incubation with SLERT in vitro ( Figure 6D , bottom panels). We found that Pol I interacted with DDX21 mainly via one RecA domain and its C-terminal domain (Figure 6D, lanes 1 and 6) . While SLERT interacted with both RecA domains of DDX21, the interaction was stronger in the presence of both RecA domains ( Figure 6D, lanes 1-3) and it barely bound to the N-or C-terminal domains ( Figure 6D, lanes 4-6) . Thus, DDX21 interacts with SLERT and Pol I via distinct but partially overlapping domains.
Because RecA domains of DDX21 are required for RNA helicase activity (Bourgeois et al., 2016) and these two domains are associated with SLERT, we asked whether the helicase activity would have an effect on pre-rRNA production. DDX21 was knocked down by shRNAs ( Figure 4I ) that target its 3 0 UTR, followed by introduction of either wide-type DDX21 or the helicase null (Perlaky et al., 1997) DDX21 DEV (DEVD to HGVD) or DDX21 SAT (SAT to LET) mutants into DDX21 KD cells. Consistent with Figure 4I , the level of pre-rRNA was increased after DDX21 KD in PA1 cells, and importantly, this effect could be rescued by both wild-type and two mutants of DDX21 lacking helicase activity ( Figures S7D and S7E ), suggesting that Pol I transcription regulation by DDX21 is unlikely to be associated with its helicase activity.
The distinct binding capability of different domains of DDX21 with SLERT and Pol I let us ask whether the allosterically altered DDX21 upon SLERT depletion could result in altered binding capability to Pol I. CoIP experiments revealed that interaction between DDX21 and RPA194 increased to $3-fold in cells lacking SLERT ( Figure 6E ), indicating that the ''open'' DDX21 in the absence of SLERT enhances its interaction with Pol I (Figures 6A and 6E) . In vitro competition assays carried out with purified His-DDX21 ( Figure S2D ), GST-RPA194 ( Figure S7F ), and SLERT revealed a direct interaction between DDX21 and RPA194 (Figure 6F, lane 3) ; remarkably, such direct interaction could be almost completely interrupted by the addition of SLERT (Figure 6F , lanes 4 and 5) but not the control egfp RNA ( Figure 6F , lanes 6 and 7), confirming that SLERT specifically binding to DDX21 (Figure 3 ) impairs the interaction between DDX21 and Pol I.
Importantly, we observed a consistent increase of RPA194 occupancy to the promoter and 28S/18S regions of rDNAs in cell lines overexpressing WT-SLERT, but not egfp-SLERT (Figure 6G) , and a consistent decrease of RPA194 occupancy to rDNAs in SLERT KO cell lines ( Figure 6H ). These observations suggest that a stronger interaction between DDX21 and Pol I ( Figures 6E and 6F ) can redirect Pol I complexes away from rDNAs in the absence of SLERT, consistent with the observation that knockdown of DDX21 to remove the suppression on Pol I led to increased Pol I occupancies to rDNA clusters ( Figure 4L ). Together, these results support a model where depletion of Figures S4A-S4E ). rDNA repeats were detected by DNA FISH with a probe recognizing the rDNA repeat unit shown in Figure S4D. (B) Pre-rRNAs coat individual DDX21 ring-shaped arrangements. A representative image of costaining DDX21 (green) and pre-rRNAs (red) by SIM and three rings in single z section in PA1 cells is shown. Pre-rRNAs were detected by FISH with a probe shown in Figure 2D . SLERT allosterically alters individual DDX21 molecules leading to enhanced interaction between DDX21 and Pol I, tightened DDX21 rings surrounding Pol I complexes, and subsequent suppression of rDNA transcription by Pol I ( Figure 7A ).
SLERT Promotes Tumorigenesis
It is well-established that dysregulated rRNA synthesis by Pol I is associated with uncontrolled cancer cell proliferation, and Pol I is a potential therapeutic target (Nguyen et al., 2015; Peltonen et al., 2014) . The observation that SLERT augmented Pol I transcription via DDX21 ( Figure 7A ) led us to examine whether altered SLERT levels would affect cell proliferation. Colony formation assays revealed that the loss of SLERT impaired cell growth ( Figure 7B) . Furthermore, mice with xenografts of SLERT KO cells developed smaller tumor mass than those of control cells ( Figure 7C ). Moreover, OE of WT-SLERT, but not egfp-SLERT, promoted colony formation ( Figure 7D ) and cell proliferation ( Figure 7E ), excluding a potential role of box H/ACA snoRNAs in tumorigenesis. These experiments strongly argue that a high level of SLERT in cells is biologically relevant in tumorigenesis, and the interaction between SLERT and DDX21 represents a potential therapeutic target for future anti-cancer drug discovery.
DISCUSSION
rDNA is the most highly transcribed region of the eukaryotic genome and more than 60% of total cellular transcription results from Pol I activity (Warner, 1999) . The Pol I complex contains 14 subunits in eukaryotes, and a number of factors are known to regulate Pol I transcription, with most of them acting at the initiation stage by promoting Pol I activity (Boisvert et al., 2007; Goodfellow and Zomerdijk, 2013; Nguyen et al., 2015; Schneider, 2012) . In order to achieve a balance between cellular growth requirements and rRNA production, Pol I transcription needs to be precisely monitored and calibrated in cells. However, few suppressors of Pol I transcription have been reported. Here, we report two previously unknown factors, SLERT and DDX21, that work together to regulate Pol I transcription. DDX21 forms ring-shaped arrangements surrounding multiple Pol I complexes, and SLERT is a key regulatory RNA that remodels the clamp of DDX21 rings acting on Pol I ( Figure 7A ). DDX21, also named RNA helicase II or Gu (a) protein, was first identified from nuclear extracts of HeLa cells (Flores-Rozas and Hurwitz, 1993) . It has RNA unwinding activity (Perlaky et al., 1997; Valdez et al., 1996) and is involved in pre-rRNA processing (Henning et al., 2003; Holmströ m et al., 2008; Sloan et al., 2015) . Calo et al. (2015) have recently reported that DDX21 associates with Pol I and Pol II transcribed genes to coordinate transcription and rRNA processing. They have shown that DDX21 binds to 7SK RNA and is recruited to the promoters of Pol II-transcribed genes encoding ribosomal proteins and snoRNAs to enhance transcription in the nucleoplasm. It was also suggested that DDX21 could promote rRNA transcription, processing, and modification in the nucleolus, however, no clearly defined mechanism of action of nucleolar DDX21 was shown.
Here, we demonstrate that DDX21 molecules in the nucleolus form ring-shaped structures that are coupled to Pol I transcription (Figure 4) . While DDX21 rings alone suppress pre-rRNA transcription, enlarged DDX21 rings upon SLERT binding can overcome such repression, leading to augmented pre-rRNA production (Figures 4 and 5) . At the molecular level, binding by SLERT alters individual DDX21 protein conformation, reduces their interaction with Pol I subunits, and liberates Pol I to transcribe rDNAs more actively (Figure 6 ). Although each ring is only coated by two to three SLERT lncRNAs ( Figures 4C, 5D , 5E, S1A, and S4G), one SLERT is able to bind to multiple DDX21 molecules ( Figure 3G ) at preferred places on individual rings ( Figures 5D and 5E ). Thus, it is attractive to speculate that the SLERT-DDX21-regulated Pol I transcription occurs at where SLERT binds in individual rings, and such regional changes can affect DDX21 and Pol I interaction, and subsequently, the extent of Pol I occupancies to transcribed rDNA clusters (Figures 6 and 7A) . Consistently, we observed that SLERT depletion led to a dramatic reduction of pre-RNA transcription (Figure 2 ). Of note, the level of SLERT expression, which is $200 copies per cell ( Figure S1A ), is much less abundant than that of other core components of the Pol I machinery. So, how is the level of SLERT expression reconciled to the extent of its impact on Pol I transcription? Indeed, SLERT copy number per cell is comparable to the number of active rDNA genes per cell, as only a fraction of the 400 rDNA genes remain transcriptionally active in any cell type (Boisvert et al., 2007) . Together, these findings represent an important mechanism in controlling the differential expression of rDNA genes within a specific NOR cluster ( Figure 7A ). The proposed regulation can be prevalent, supported by the observation that all detectable Pol I complexes in examined human cells are surrounded by DDX21 rings and SLERT (Figures 4, S3 , and S6).
We do not yet know how many DDX21 molecules are required to form one DDX21 ring around multiple Pol I complexes. Using SIM and stoichiometric quantity of whole cellular extracts plotting with purified DDX21, each DDX21 ring-shaped arrangement was estimated to contain several to over 10,000 molecules. However, as the three-dimensional arrangement of DDX21 rings and the exact assembly pattern between DDX21 molecules within each structure require improved techniques to elucidate, this number is only speculative. Nevertheless, this stoichiometric outcome raises an intriguing question: how do two to three SLERT molecules, although each binds to multiple DDX21 proteins, change conformation of the ring that contains thousands copies of DDX21 proteins? Our data support one possibility that binding SLERT to DDX21 is sufficient to elicit regionally allosterical alteration, which in turn may lead to the observed change of the ring-shaped arrangements (Figures 5 and 6 ). In addition, DDX21 rings may act beyond Pol I transcription regulation. For instance, DDX21 was reported to be involved in prerRNA processing and modification (Calo et al., 2015; Henning et al., 2003; Sloan et al., 2015) ; it is likely that the formation of DDX21 rings may coordinate pre-rRNA transcription and modification to achieve a higher pre-rRNA processing efficiency. Understanding both biochemical and structural details of the DDX21 ring, the SLERT-DDX21 complex, and interaction with Pol I complexes will be necessary to fully understand this complex regulation.
SLERT is human-specific (Zhang et al., 2014) . One of the two snoRNAs at its ends, SNORA5A, is only present in human but not Figure 3F for details). See also Figures S7A-S7C . (E) SLERT depletion leads to increased interaction between DDX21 and RPA194, revealed by coIP of DDX21 and RPA194 in control and SLERT KO PA1 cells. The relative ratio of RPA194 and DDX21 from no less than three independent experiments was determined using Quantity One software and is shown on the right. (F) SLERT impairs the binding between GST-RPA194 and His-DDX21. Purified GST-RPA194 (10 pmol) and His-DDX21 (10 pmol) were incubated in vitro in the presence or absence of SLERT or EGFP control RNA (10 pmol and 50 pmol), followed by anti-His pull-down and WB (see also Figure S7F ). Representative results are shown from three replicates.
(legend continued on next page) in mouse. Thus, no SLERT could be produced from introns of mouse TBRG4. It will be of interest to examine whether DDX21 forms similar rings in mouse cells and whether similar regulatory RNAs exist for Pol I regulation. Of note, the Pol I machinery is dedicated solely to transcribing rDNAs and is rapidly evolving, which can be exemplified by incompatibilities between mouse and human (McStay, 2006 (McStay, , 2016 . Interestingly, human SNORA5A was predicted as a guide RNA of pseudouridylation for resides 1242 and 1629 of 18S rRNA (Kiss et al., 2004) , while no such modifications were reported in mouse.
Dysregulated rRNA synthesis by Pol I is associated with cancer cell proliferation. Thus, targeting the Pol I activity could offer a therapeutic opportunity (Peltonen et al., 2014) . Modulation of SLERT expression led to impaired or promoted cell proliferation (Figure 7 ). While directly blocking Pol I transcription may cause non-specificity in potential anti-cancer drug discovery, targeting SLERT or the interaction between SLERT and DDX21 represent potential therapeutic targets for anti-cancer. In sum, our findings uncover a fundamental control of ribosome biogenesis in human cells by altering SLERT expression, changing DDX21 conformation, and modulating DDX21 ring-shaped structures that act on Pol I transcription.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
STAR+METHODS KEY RESOURCES TABLE

CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents should be directed to and will be fulfilled by the Lead Contact, Ling-Ling Chen (linglingchen@sibcb.ac.cn).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Cell Lines Human cell lines including PA1, HeLa, HEK293 cells were purchased from the American Type Culture Collection (ATCC; https://www. atcc.org).
Subcutaneous Xenograft Tumor Models
Female nude recipient mice 4-6 weeks of age were obtained from SLAC laboratory animal company and maintained under pathogenfree conditions. Cells (5 3 10 6 ) were implanted subcutaneously in a Matrigel matrix under both sides of shoulders of each mouse and allowed to grow to reach an average size of $30-40 mm 2 . Animal care and treatment were approved by the Institute Animal Care and
Research Advisory Committee at SIBCB, CAS.
METHOD DETAILS Plasmids Construction
Full-length SLERT flanked by its natural intron, splicing sites and exons was PCR amplified from the genomic DNA of PA1 cells, and the PCR product was cloned into pcDNA3 using EcoRI / NotI. All deletions and mutations of snoRNA in SLERT in the expression vector pcDNA3-SLERT wt were created using Mut Express MultiS Fast Mutagenesis Kit (Vazyme C213-01). The rDNA promoter luciferase reporter vector was constructed according to previous study (Ghoshal et al., 2004) . Briefly, the Kozak sequence from pGL3-Basic Vector (Promega) was removed by NcoI and XhoI digestion and the internal ribosome entry site (IRES) was amplified from pHAGE-EF1a-IRES-ZsGreen Vector and cloned into the same site with XhoI and NcoI. Then the rDNA promoter region (from À411 to +329 containing both UCE and CPE) was PCR amplified from the genomic DNA of PA1 cells and cloned into pGL3-Basic Vector using KpnI and MluI. See Table S1 for primers. The oligonucleotides for shRNA targeting DDX21 were cloned into pLKO.1-Puro vectors. A scramble shRNA plasmid was used as a negative control. Two shRNAs (5 0 -CCCATATCTGAAGAAACTATT-3 0 and 5 0 -GGTGGCTCCATAGCTTT ATTT-3 0 ) produced the best knockdown efficiency. For overexpression full-length or truncated DDX21, PCR products of full-length or series truncation of DDX21 were amplified from cDNA of PA1 cells, and inserted into pHAGE-EF1a-IRES-ZsGreen expression vectors with flag tag on their N-terminal.
For prokaryotic expression and purification of the His-tagged DDX21 protein, the full-length DDX21 DNA sequence was amplified from cDNAs of PA1 cells, and inserted into pET-28a vector using BamHI and NotI. For eukaryotic expression and purification of the GST-tagged RPA194, the PCR product of the full-length RPA194 DNA fused with GST was inserted into the EGFP depleted pEGFP-C1 plasmid. See Table S1 for primers.
To construct the DDX21 FRET reporter plasmid, the full-length DDX21 together with EGFP fused to its N-terminal and mCherry fused to its C-terminal, DDX21 with EGFP fused to its N-terminal, and DDX21 with mCherry fused to its C-terminal were cloned into the pHAGE expression vector that lacks IRES-ZsGreen sequences. For live cell imaging, EGFP-DDX21 and DDX21-mCherry PCR products were obtained from DDX21 reporter plasmid and cloned into pcDNA3 vector; PCR products of the full-length RPA194 and RPA49 was individually amplified from cDNA of PA1 cells and inserted into pEGFP-C1 vector. See Table S1 for primers.
Cell Culture, Cell Transfection and Lentiviral Infection PA1 cells were maintained in MEMa supplemented with 10% FBS, 1% Glutamine and penicillin/streptomycin. HeLa cells were maintained in DMEM supplemented with 10% FBS and penicillin/streptomycin. Transfection of pcDNA3 constructs was carried out with X-tremeGENE 9 (Roche) for HeLa cells (60%-70% confluence) according to the manufacturer's protocol. Lentiviral particles were produced in HEK293T cells by transient co-transfection of transfer vector constructs (pLKO.1-Puro vectors or pHAGE-EF1a-IRES-ZsGreen expression vectors), pCMV-VSV-G and pMD2.G.
Protein Expression and Purification
His-tagged full-length DDX21 in pET-28a was transformed into E.coli expression strain BL21 [Transetta (DE3) chemically competent cell (TRANSGEN BIOTECH, CD801)] for expression. 5 mL LB culture supplemented with 100 mg/L kanamycin was inoculated with a single colony at 250 rpm, 37 C. After overnight growth, the culture was diluted 100-fold into 100 mL LB culture supplemented with 100 mg/L kanamycin. Absorbance was monitored at a wavelength of 600 nm, and upon reaching an optical density (OD600) of 0.4, protein expression was induced by adding of 1 mM IPTG. After overnight incubation at 250 rpm, 16 C, cell pellets were harvested by centrifugation (5,000 rpm, 10 min, 4 C). Cell pellets were resuspended in lysis buffer (50 mM Tris pH 8.0, 300 mM NaCl, 20 mM imidazole, 1 mM PMSF) supplemented with 1 mg/ml lysozyme, and stored on ice for 30 min, followed by 10 min (5 s on/off) sonication on ice. After centrifugation at 10,000 rpm for 30 min at 4 C, the supernatant cell lysates were incubated with Ni Sepharose (GE healthcare, 17-5318-01) for 2 hr at 4 C. The Sepharose was washed 4 times with washing buffer (50 mM Tris pH 8.0, 300 mM NaCl, 40 mM imidazole, 1 mM PMSF), and bound protein was eluted with elution buffer (50 mM Tris pH 8.0, 300 mM NaCl, 300 mM imidazole). Elution was repeated twice to gain maximum yield. The concentration of purified protein was determined by using Modified Bradford Protein Assay Kit (Sangon Biotech, C503041) and checked by SDS-PAGE.
GST-tagged full-length RPA194 in pEGFP-C1 was transfected into HEK293 cells for expression. Cells were harvested after 2 days to achieve optimal expression and purity. 2 3 10 8 HEK293 cells were resuspended in lysis buffer (20 mM Tris pH 8.0, 100 mM NaCl, 1 mM PMSF, Complete EDTA free protease inhibitor (Roche), 5 mM Benzamidine) and lysed by 2 3 10 s sonication. After centrifugation at 13,000 rpm for 10 min at 4 C, supernatant cell lysates were incubated with Glutathione Sepharose (GE healthcare, 17-0756-01) for 2 hr at 4 C. The Sepharose was washed 4 times with lysis buffer, and bound protein was eluted with elution buffer (50 mM Tris pH 8.0, 20 mM Glutathione). Elution was repeated twice to gain maximum yield. The concentration of purified protein was determined using Modified Bradford Protein Assay Kit (Sangon Biotech, C503041) and checked by SDS-PAGE.
Isolation of Nucleoli
Nucleoli isolation in PA1 cells was performed as described (Hacot et al., 2010) with modifications. 2 3 10 7 PA1 cells were used for nucleoli isolation. Cell pellet was suspended by gentle pipetting in 200 mL lysis buffer (10 mM Tris pH 8.0, 140 mM NaCl, 1.5 mM MgCl 2 , 0.5% Igepal, 2 mM Ribonucleoside Vanadyl Complex), and incubated on ice for 10 min. During the incubation, one tenth of the lysate was added to 1 mL Trizol for total RNA extraction. The rest of the lysate was centrifuged at 1000 rpm for 3 min at 4 C to pellet the nuclei and the supernatant was the cytoplasmic fraction. To fractionate nuclear fractions, nuclei pellet was resuspended with 200 mL 340 mM sucrose solution containing 5 mM MgCl 2. One tenth of the lysate was added to 1 mL Trizol for nuclei RNA extraction. To prepare nucleoplasmic and nucleolar fractions, nuclei were broken by sonication until intact nuclei cannot be detected in suspension by microscope. 200 mL 880 mM sucrose solution containing 5 mM MgCl 2 was gently added to sonicated nuclei and then centrifuged 20 min at 2,000 rpm, 4 C to pellet nucleoli, and the supernatant was the nucleoplasmic fraction. Fractionated RNAs from the same amount of cells were used for cDNA synthesis and RT-PCR.
RNA Isolation, qRT-PCR and Northern Blotting
Total RNA from each cultured cell line or cultured cells with different treatments was extracted with Trizol Reagent (Invitrogen) according to the manufacturer's protocol. For qRT-PCR, after treatment with DNase I (Ambion, DNA-free kit), the cDNA synthesis was carried out using SuperScript III (Invitrogen) with oligo (dT) and random hexamers. QPCR was done using SYBR Green Realtime PCR Master Mix (TOYOBO) and a StepOnePlus real-time PCR system (Aplied Biosysterms). The relative expression of different sets of genes was quantified to actin mRNA. Primer sequences for qRT-PCR and RT-PCR used were listed in Table S1 .
Northern blotting was carried out according to the manufacturer's protocol (DIG Northern Starter Kit, Roche). RNA was loaded on native Agarose gels or denatured PAGE gels. Digoxigenin (Dig) labeled antisense probes were generated using T7 RNA polymerase by in vitro transcription with the RiboMAX Large Scale RNA Production System (Promega).
Measurement of SLERT Copy Numbers
A serial dilution of the linearized plasmid pcDNA3-WT-SLERT was used qRT-PCR to generate a standard curve for SLERT. The copy number of the diluted plasmid pcDNA3-WT-SLERT was calculated by DNA/RNA Copy Number Calculator from website (http:// endmemo.com/bio/dnacopynum.php). To measure the SLERT copy number in PA1 or H9 cells, total RNA extracted from 2 3 10 6 cells of each line was reverse transcribed into cDNAs for qPCR analysis, and the copy number could be quantitated from the standard curve. See Table S1 for primers.
RNA In Situ Hybridization and Immunofluorescence Microscopy
To detect SLERT, RNA FISH was carried out as previously described with in vitro transcribed Dig-labeled antisense probe (Yin et al., 2012) . Briefly, cells were fixed with 3.6% PFA and 10% acetic acid for 15 min, followed by permeabilization with 0.5% Triton X-100 for 5 min on ice. Then cells were subjected to incubation with denatured Dig-labeled FISH probes in hybridization buffer (50% formamide in 2xSSC) at 50 C overnight. After hybridization, anti-Dig primary antibody and fluorescent secondary antibody were sequentially added to visualize signal with DeltaVision Elite imaging system (GE Healthcare). The nuclei were counterstained with DAPI. For colocalization studies, cells were co-stained with mouse anti-Nucleolin (Abcam), mouse anti-B23 (Santa Cruz Biotechnology), rabbit anti-fibrillarin (abcam), rabbit anti-DDX21 (Proteintech), and mouse anti-RPA194 (Santa Cruz Biotechnology).
RNA/DNA Double FISH Sequential RNA/DNA double FISH experiments were carried out after RNA FISH. Cells were denatured at 80 C for 5 min in prewarmed 2 3 SSC and 70% deionized formamide, pH 7.0. Next, cells were hybridized with denatured DNA probe prepared from Nick Translation (Abbott) overnight. After hybridization, two washes of 10 min at 37 C with 50% formamide in 2 3 SSC were performed, followed by two washes of 15 min at 37 C with 1 3 SSC and two washes of 15 min at 37 C with 2 3 SSC. Slides were then mounted with ProLong Gold antifade reagent (Thermo Fisher SCIENTIFIC) with DAPI. Analysis was performed on single Z stacks acquired with a DeltaVision Elite imaging system (GE Healthcare). Primers for probes were listed in Table S1 .
Structured Illumination Microscopy Procedure
For all SIM experiments, cells were seeded on High Performance No.1.5 18 3 18mm glass coverslips (Schott Nexterion), fixed and permeabilized as described previously (Wu et al., 2016) . 1). To visualize DDX21 and RPA194, cells were blocked with 1% BSA for 1h. Antibodies were 1:200 diluted in blocking buffer and incubated for 1 hr at RT. After washing with 1xPBS 3 times, fluorescent secondary antibodies were 1:2,000 diluted in blocking buffer and incubated for 1 hr at RT. Samples were mounted in Vectashield antifade mounting medium (Vector Lab). 2) To visualize SLERT, DDX21 and RPA194, cells were incubated in 50% formamide/2xSSC at RT for 10 min. A set of Cy3-labeled nick translation and denatured probes targeting SLERT were added and hybridize at 37 C in a humid chamber for 16 hr. Unbound probes were washed away by 50% formamide/2xSSC. For subsequent immunostaining, cells were stained as described above. 3) To visualize DDX21, RPA194 and rDNA, cells were incubated in 2xSSC at RT for 10min, then incubated with 2 mg/ml RNaseA in 2xSSC at 37 C for 1 hr. After RNaseA treatment, the samples were washed with 2xSSC for 5 times and incubated in 70% formamide/2xSSC at RT for 10 min. Then cells were denatured in prewarmed 85 C 70% formamide/ 2xSSC for 8 min and chill in the pre-cool 50% formamide/2xSSC on ice. A set of Cy3-labeled and denatured dsDNA probes targeting rDNA were added to the samples and hybridize at 37 C in a humid chamber for at least 16 hr. After hybridization, the samples were treated as described above to visualize DDX21 and RPA194. Primers for probes were listed in Table S1 .
After performed FISH and/or IF, SIM was performed on a DeltaVision OMX V4 system (GE Healthcare) equipped with a 60 3 /1.42 NA Plan Apo oil-immersion objective (Olympus) and six laser beams (405, 445, 488, 514, 568 and 642nm) . The microscope was routinely calibrated with a special image registration slide and algorithm provided by GE healthcare. To obtain optimal images, immersion oil with refractive indices of 1.516 was used at 25 C room temperature. SI image stacks were captured with a z-distance of 0.125 mm and with 5 phases, 3 angles, 15 raw images per plane. The raw data were reconstructed with channel-specific OTFs and a Wiener filter was set to 0.002 for A568 and FITC channels and 0.004 for DAPI and A647 channel by using softWoRx 6.5 package (GE Healthcare). Images were registered with alignment parameters obtained from calibration measurements with 100 nm diameter TetraSpeck Microspheres with four colors (Molecular Probes).
Structured Illumination Microscopy Imaging Analysis
All SIM images were cropped and processed by Fiji/ImageJ. Calculation of diameters of DDX21 ring-shaped structures was performed by Tango plug-in (Ollion et al., 2013) . In brief, these ring-like arrangements were segmented according to a set of defaulting parameters: (1) subtract background 2D: Rolling ball method with a 10-pixel radius; (2) adaptive fast 3D filter with a 1-pixel radius in x, y, z; (3) OTSU AutoThreshold segment; (4) size filter with a minimal volume of 100 and remove objects touching x, y, z; (5) fill holes 2D. All DDX21 ring-shaped structures generated by auto-segmentation described above were manually chosen by naked eyes and only the successfully segmented rings were measured. Diameter of DDX21-rings was measured by Measure Geometrical Simple: FeretMax function in Tango plug-in.
Calculation of the integrated fluorescence intensity of pre-rRNA and the diameter of corresponding DDX21 ring-shaped structure was performed by Tango plug-in. Briefly, the reconstructed images were converted to 8 bit and imported into Tango. The DDX21-rings were segmented according to a set of defaulting parameters: (1) subtract background 2D: Rolling ball method with a 5 pixel radius; (2) choose image features by structure method with smooth scale of 0.5-pixel and integration scale of 0.5 pix; (3) OTSU AutoThreshold segment; (4) size filter with a minimal volume of 50 and remove objects touching x, y, z; (5) fill holes 2D; (6) binary close, radius = 2. All DDX21 ring-shaped structures generated by auto-segmentation described above were manually chosen by naked eyes and only the successfully segmented rings were then measured. The pre-rRNA signal in each ring was segmented as follow: (1) subtract background 2D: Rolling ball method with a 50 pixel radius; (2) OTSU AutoThreshold segment; (3) binary dilate with 2 radius in x, y, and z. The intensity of pre-rRNA was measured by integrated density of signal quantification function and the diameter of each DDX21 ring-like structure was measured by Measure Geometrical Simple: FeretXY function. See Figures S5A and 5C .
The measurement of integrated fluorescence intensity of corresponding SLERT is similar as above, but without the post-filters of binary dilate for a more accurate calculation for overlapping SLERT signal on individual DDX21-rings. Of note, the data exported from Tango was then regressed by SPSS using the power function as follow: y = ax b , where y denotes the diameter of DDX21-ring while x denotes the integrated fluorescence intensity of SLERT on the correspondent ring. The significance test of the nonlinear regression was performed after taking the log of both x and y, which is a linearization procedure of the nonlinear regression. See Figures S5B and 5G.
Live Cell Imaging All live cell imaging was carried out on a DeltaVision Elite imaging system (GE Healthcare), equipped with a 60 3 /1.42 NA Plan Apo oil-immersion objective, 100 3 /1.40 NA Plan Apo oil-immersion objective (Olympus) and live cell imaging environment control system (Live Cell Instrument). Cells were cultured on 29 mm No.1.5 glass bottom dishes (Cellvis). DDX21-EGFP, DDX21-mCherry, EGFP-RPA194/DDX21-mCherry or EGFP-RPA49/ DDX21-mCherry was transfected into cells 48 hr prior to imaging by X-tremeGENE 9 (Roche). Cells were washed once with PBS and the medium was replaced by FluoroBrite DMEM (GIBCO) supplemented with 10% FBS and 4 mM GlutaMax supplement and placed back in the incubator for 1 hr. For imaging of the single time point, six z sections with 0.2 mm spacing were acquired and for imaging of time lapse, cells were imaged in single layer per 15 s for single channel or per 30 s for double channels. For presentation in figures, raw data were deconvoluted by softWoRx 6.5 using the enhanced ratio method and cropped by Fiji/ImageJ (Schindelin et al., 2012) .
Knockout SLERT by CRISPR/CAS9 Two sgRNAs (5 0 -CATGAGTCACAGTGTTTCTG-3 0 and 5 0 -ATGAGCTGTG GAGCTTGCTG-3 0 ) that target the box H of SNORA5A and SNORA5C respectively were individually inserted into PX330 plasmid (Addgene). Transfection plasmids in PA1 cells was carried out with Lipofectamine 2000 Reagent (Thermo) according to the manufacturer's instructions. Genomic DNA and total RNA of selected single clones were extracted either for the genotyping validation with appropriate sets of primer listed in Table S1 or for knockout efficiency validation by qRT-PCR and Northern blotting in Figures 2A-2C , S1H, and S1I.
Collection and Quantification of Nascent pre-rRNA PA1 cells (1 3 10 7 ) were pretreated with 20 mM 5-fluorouracil (5-FU) for 3 hr to halt rRNA processing (Zhang et al., 2011 ) and pulsechased with 100 mM 4-thiouridine (4sU) to monitor nascent pre-rRNA levels in the last 30 min period. Total RNA was extracted and used for biotinylation and purification of 4sU-labeled nascent RNA. 100-140 mg 4sU-labeled total RNA was incubated in biotinylation buffer (10 mM Tris pH 7.4, 1 mM EDTA) with 0.2 mg/ml EZ-link biotin-HPDP (Pierce, 21341), which was dissolved in dimethylformamide (DMF, Sigma, D4551) at a concentration of 1 mg/ml at room temperature for 1.5 hr with rotation. Unbound biotin-HPDP was removed by equal volume chloroform extraction twice, and RNA was precipitated at 13,000 rpm for 15 min at 4 C with 1:10 volume of 5 M NaCl and an equal volume of isopropanol. The RNA pellet was washed twice with 75% ethanol and resuspended in 150 mL DEPC,H 2 O. RNA quality was checked by electrophoretical analysis to exclude RNA degradation. 4sU-labeled and unlabeled RNA was separated using streptavidin-coated magnetic beads (Invitrogen). Biotinylated RNA was incubated with 150 mL Streptavidin beads at room temperature for 20 min. Beads were washed four times with 0.9 mL of 65 C washing buffer (100 mM Tris pH 7.4, 10 mM EDTA, 1 M NaCl, 0.1% Tween 20), followed by four times with 0.9 mL of room temperature washing buffer. Nascent RNA was eluted with 100 mL 0.1 M dithiotheitol (DTT) twice, and RNA was precipitated with 40 mL of 4 M LiCl, 2 mL glycogen and 600 mL ice-cold ethanol.
Dual Luciferase Reporter Assay
For rDNA promoter luciferase assay, SLERT KO cells and control cells were seeded in 96-well plate and co-transfected with pGL3-rDNA-IRES reporter and Renilla luciferase vector using Lipofectamine 2000 Reagent (Invitrogen). The transfection ratio of pGL3-rDNA-IRES and the Renilla luciferase vector was 4:1, and the Renilla luciferase vector was used as an internal control for normalization. 24 hr after transfection, the luciferase activity was measured using Dual-Glo Luciferase Assay System (Promega) according to manufacturer's instructions.
Ribosome Fractionation
SLERT KO and control cells were exposed to cycloheximide (100 mg/ml) for 15 min, then 2 3 10 7 cells were lysed in 500 mL lysis buffer containing 20 mM Tris pH7.4, 15 mM MgCl 2 , 200 mM KCl, 1% Triton X-100, 100 mg/ml cycloheximide, 1 mM DTT, 1 mg/ml heparin and 40 U/ mL RNasin (Promega). The samples were centrifuged at 13,000 rpm at 4 C for 10 min. For fractionation, the lysates were loaded on 15%-45% sucrose gradients and separated by ultracentrifugation with a SW41 rotor (Beckman) at 36,000 rpm at 4 C for 2.5 hr. Linear sucrose gradients were prepared with a Gradient Master (Biocomp) as indicated by the manufacturer. The distribution of ribosomes on the gradients was recorded using BIOCOMP Piston Gradient Fractinator equipped with BIO-RAD ECONO UV Monitor (set at 254 nm).
tRSA RNA Pull-down Assay and Western Blotting tRSA RNA pull-down assays were carried out as described (Iioka et al., 2011) with modifications. SLERT full-length or internal sequence was cloned into pcDNA3 plasmid with the tRSA tag at its 5 0 end. RNA products were in vitro transcribed using the T7 RiboMAX Large-Scale RNA Production System (Promega). 10 mg per reaction of synthetic RNAs were denatured for 5 min at 65 C in RNA Structure buffer (10 mM HEPES pH 7.0, 10 mM MgCl 2 ) and slowly cooled down to room temperature. Then, folded RNAs were incubated with 50 mL of streptavidin Dynabeads (Invitrogen) for 20 min at 4 C in the presence of 2 U/ml RNasin (Promega). PA1 cells (1 3 10 7 ) were harvested and resuspended in 1 mL of lysis buffer [10 mM HEPES pH 7.0, 200 mM NaCl, 1 mM DTT, 1%
Triton X-100, protease inhibitor cocktail (Roche)] followed by sonication for 4 3 10 s with an interval of 1 min on ice and then centrifuged at 13,000 rpm for 10 min at 4 C. The supernatant was pre-cleared with 50 mL of streptavidin Dynabeads for 20 min at 4 C followed by the addition of 20 mg/ml yeast tRNA for 20 min at 4 C. Then the pre-cleared lysate was added to folded RNAs and incubated for 3.5 hr at 4 C followed by washing 4 3 5 min with wash buffer [10 mM HEPES pH 7.0, 400 mM NaCl, 1 mM DTT, 1% Triton X-100, protease inhibitor cocktail (Roche), 2 mM RVC]. To harvest the protein complex, 50 mL of 1 3 SDS loading buffer was added and boiled for 10 min at 100 C. Retrieved proteins were analyzed by WB with primary antibodies anti-DKC1 (Abcam), anti-DDX21 (Proteintech) and anti-hnRNP U (abcam).
Silver Staining and Mass Spectrometry
After tRSA pull-down, equal amounts of proteins were loaded on NuPAGE 4%-12% Bis-Tris Gel (Invitrogen). Then the gel was stained using Pierce Silver Stain for Mass Spectrometry kit (Thermo Fisher Scientific) according to the manufacturer's instructions. After silver staining, specific bands were cut and sent to Core Facility of Molecular Biology (Institute of Biochemistry and Cell Biology, Shanghai, CAS) for mass spectrometry analysis.
Native RNA-Protein Complex Immunoprecipitation PA1 cells (1 3 10 7 ) were harvested, resuspended in 1 mL lysis buffer [50 mM Tris pH 7.4, 150 mM NaCl, 0.05% Igepal, 0.5% NP-40, 0.5 mM PMSF, 2 mM RVC, protease inhibitor cocktail (Roche)] followed by 4 3 10 s sonication with an interval of 1 min on ice. After centrifuging at 13,000 rpm for 10 min at 4 C, the supernatant was pre-cleared with 15 mL Dynabeads Protein G (Invitrogen). The precleared lysates were further incubated with 2 mg anti-DDX21 antibody (Proteintech) for 2 hr at 4 C. Then 15 mL Dynabeads Protein G beads (blocked with 1% BSA and 20 mg/ml yeast tRNA) were added to the mixture and incubated for another 1 hr at 4 C followed by washing with wash buffer [50 mM Tris pH 7.4, 300 mM NaCl, 0.05% Sodium Deoxycholate, 0.5% NP-40, 0.5 mM PMSF, 2 mM RVC, protease inhibitor cocktail (Roche)]. The RNA-protein complex was eluted with elution buffer (100 mM Tris pH 6.8, 4% SDS) at room temperature for 15 min. For qRT-PCR, each RNA sample was treated with DNase I (Ambion, DNA-freeTM kit) and then reverse transcription was performed with SuperScript III Reverse Transcriptase (Invitrogen) with oligo (dT) and random hexamers followed by qRT-PCR analysis. Primers were listed in Table S1 .
Formaldehyde Crosslinking RNA Immunoprecipitation PA1 cells (1 3 10 7 ) were harvested and suspended in 10 mL PBS with 1% formaldehyde to fix 10 min at room temperature. Crosslinking was stopped by the addition of glycine to a final concentration of 0.25 M followed by incubation at room temperature for 5 min. After pelleting cells at 1,000 rpm for 5 min, the cell pellet was resuspended in 1 mL RIPA buffer [50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% Sodium Deoxycholate, 1 mM PMSF, 2 mM RVC, protease inhibitor cocktail (Roche)] followed by 8 3 10 s sonication with an interval of 1 min on ice. After centrifuging at 13,000 rpm for 10 min at 4 C, the supernatant was pre-cleared with 15 mL Dynabeads Protein G (Invitrogen) and 20 ìg/ml yeast tRNA at 4 C for 30 min. Then the pre-cleared lysate was incubated with beads that were pre-coated with 2 ìg anti-DDX21 antibody (Proteintech) for 4 hr at 4 C. The beads were washed 4 3 5 min with washing buffer I (50 mM Tris pH 7.4, 1 M NaCl, 1% NP-40, 1% Sodium Deoxycholate), and 4 3 5 min with washing buffer II (50 mM Tris pH 7.4, 1 M NaCl, 1% NP-40, 1% Sodium Deoxycholate, 1 M Urea). The complex was eluted from beads by adding 140 mL elution buffer (100 mM Tris pH8.0, 10 mM EDTA, 1% SDS). To reverse crosslinking, 4 mL 5 M NaCl and 2 mL 10 mg/ml proteinase K were added into the RNA samples, and incubated at 42 C for 1 hr followed by another hour inculation at 65 C. RNA was then extracted, digested with DNase I (Ambion) and used to synthesize cDNA with SuperScript III Reverse Transcriptase (Invitrogen) with oligo (dT) and random hexamers followed by qRT-PCR analysis. Primers were listed in Table S1 .
Co-Immunoprecipitation PA1 cells or PA1 cells expressing flag-DDX21 or flag-DDX21 truncations (2 3 10 7 ) were harvested and suspended in 1 mL lysis buffer [50 mM Tris pH 7.4, 150 mM NaCl, 0.05% Igepal, 0.5% NP-40, 0.5 mM PMSF, 2 mM RVC, protease inhibitor cocktail (Roche)] followed by 3 3 10 s sonication. After incubation with 2 mg anti-DDX21 antibody (Santa Cruz) or anti-flag M2 antibody (Sigma), the beads were washed 4 3 5 min with wash buffer [50 mM Tris pH 7.4, 300 mM NaCl, 0.05% Sodium Deoxycholate, 0.5% NP-40, 0.5 mM PMSF, 2 mM RVC, protease inhibitor cocktail (Roche)]. To harvest the protein complex, 50 mL of 1 3 SDS loading buffer (62.4 mM Tris pH 6.8, 10% glycerol, 2% SDS, 0.0012% bromophenol blue) was added, boiled for 10 min at 100 C, and analyzed by western blotting.
In vitro Competition Binding Assay
Ni Sepharose (GE Healthcare) was washed twice and resuspended with 1 mL binding buffer [50 mM Tris pH 7.4, 150 mM NaCl, 0.1mM DTT, 0.5 mM PMSF, 2 mM RVC, protease inhibitor cocktail (Roche)]. Then 10 pmol each of His-DDX21 and GST-PRA194 purified proteins were added to the washed Ni Sepharose, together with or without 10 pmol or 50 pmol RNAs. The binding reactions were incubated 1 hr at 4 C, followed by 3 times washing with 1 mL binding buffer. To harvest the protein complex, 50 mL of 1 3 SDS loading buffer was added and boiled for 10 min at 100 C. Retrieved proteins were analyzed by WB.
Dig-Labeled RNA Pull-down Assay Dig-RNA pull-down assays were carried out as described (Hu et al., 2015) with modifications. 2 3 10 7 PA1 cells or PA1 cells expressing flag-DDX21 or flag-DDX21 truncations were used to immunoprecipitate with either anti-DDX21 (Santa Cruz) or anti-flag M2 (Sigma) antibodies. After immunoprecipitation and wash, one-fourth beads was saved for WB. The rest was equilibrated in binding buffer [50 mM Tris-HCl at pH 7.4, 150 mM NaCl, 0.05% Igepal, 0.5% NP-40, 0.5 mM PMSF, 2 mM RVC, protease inhibitor cocktail (Roche)] and incubated with 300 ng of Dig-labeled RNA for 4 hr at 4 C. For SLERT truncations, the same mole transcripts were used for protein binding assay. After washing 4 3 5 min with binding buffer, the bound RNAs were extracted and analyzed by denatured PAGE gel.
Electrophoretic Mobility Shift Assay
The Dig-labeled RNAs were annealed by heating at 65 C for 5 min, then slowly cool down to room temperature. 1 fmol of the labeled RNAs were used for each EMSA reaction. Protein-RNA binding was carried out with indicated amount of purified protein and annealed Dig-labeled RNA in binding buffer [100 mM HEPES pH7.5, 200 mM KCl, 10 mM MgCl2, 10 mM DTT (DL-Dithiothreitol)]. Binding reactions were incubated at room temperature for 25 min, then immediately loaded onto a 8% nondenaturing polyacrylamide 0.5 3 TBE gel. The gel was transferred to nylon membrane, and imaged by incubation with Anti-Digoxigenin-AP Solution.
Fö rster Resonance Energy Transfer Assay FRET efficiency was measured with donor dequenching approach as described (Seegar and Barton, 2010) with modifications. SLERT KO and control PA1 cells were infected with DDX21 FRET reporter lentivirus. 24 hr later, cells were fed with pre-warmed fresh medium and then infected the second time with the same virus on the plates. 2 days after the 1st infection, cells were treated with trypsin, and plated on glass coverslips growing for another 24 hr. After fixing with 4% PFA for 10min at room temperature, the coverslips were mounted on the slide and ready for Confocal imaging analysis. Cell imaging was performed on a Leica TSC SP8 STED 3X confocal laser scanning microscope (Leica) with Leica software acceptor photo-bleaching program. In brief, zooming onto cells of interest, highlighting an ROI (region of interest) in which the photo-destruction of the acceptor (mCherry) occurred and began the program. For photo-destruction of the acceptor, cells were photo-bleached with 561 nm laser line (set at 100% intensity, 5 times). The images were captured in both channels before and after photo bleaching. In all experiments, about 30 cells were measured, and FRET efficiency was calculated as E = (1-Pre/Post) 3 100%, where Pre and Post represent the intensity of donor (EGFP) fluorescence before and after photo bleaching.
Chromatin Immunoprecipitation PA1 cells (1 3 10 7 ) were harvested and suspended in 10 mL PBS with 1% formaldehyde to fix 10 min at room temperature. Crosslinking was quenched by the addition of glycine to a final concentration of 0.25 M followed by incubation at room temperature for 5 min. After pelleting cells at 1,000 rpm for 5 min, the cell pellet was resuspended in 1 mL lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.1% Sodium Deoxycholate) followed by sonication with S220 Focused-ultrasonicators (Covaris) to achieve 300-500 bp DNA fragments. After centrifugation at 16,000 g for 10 min at 4 C, the supernatant was pre-cleared with 15 mL Dynabeads Protein G (Invitrogen) with 100 mg BSA and 100 mg ssDNA. Then the precleared lysates were incubated overnight at 4 C with 2 mg anti-Pol I antibody (Santa Cruze) or anti-DDX21 (Proteintech). The beads were washed with 600 mL lysis buffer, 600 mL high salt wash buffer (1% Triton X-100, 0.1% Sodium Deoxycholate, 50mM Tris-HCl at pH8.0, 0.5 M NaCl, 5 mM EDTA), 600 mL LiCl immune complex wash buffer (0.25 M LiCl, 0.5% Igepal, 0.5% Sodium Deoxycholate, 10 mM Tris pH 8.0, 1 mM EDTA) sequentially, followed by two washes with 600 mL TE Buffer (10 mM Tris pH 8.0, 1 mM EDTA) at 4 C. The complex was eluted by adding 200 mL fresh-prepared elution buffer (1% SDS, 0.1 M NaHCO 3 ) with rotation at room temperature for 15 min. Then the reverse crosslinking was carried out by adding 8 mL 5 M NaCl and incubated at 65 C for 4 hr, followed by supplemented with 4 mL 0.5 M EDTA and 10 mL proteinase K (10 mg/ml) at 55 C for 2 hr. DNAs were purified by phenol/chloroformextraction extraction and ethanol precipitation by adding 20 mg yeast tRNA. The pellets were dissolved in 100 mL ddH 2 O for qRT-PCR. Primers were listed in Table S1 .
Soft Agar Colony Formation Assay
In 6-well plates, 2 mL bottom layer medium (1% agarose and 10% FBS) was added to per well and cooled down for 0.5h at room temperature. Then 2 mL top layer medium (0.8% agarose and 20% FBS) mixed with 5 3 10 3 cells were added to each well and cooled down for 10 min at 4 C. The cells were cultured at 37 C for 3 weeks. Then 1 mL 0.005% Crystal Violet was added to each well for 1h at room temperature for pictures and the average number of colonies per well were shown. Colonies were counted with a Zeiss LSM 510 microscope.
Cell Proliferation Assay 3 3 10 3 SLERT OE and control cells were seeded in 96-well and cell numbers were measured every 24h according to CellTiter 96
AQueous One Solution Cell Proliferation Assay (Promega). Data were presented with respect to 0h cells set to a value of 1.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were analyzed using Student's t test or Mann-Whitney Test by GraphPad Prism 6 software. Statistical significance is defined as: * p < 0.05, ** p < 0.01 and *** p < 0.001. Error bars represent SD in triplicate experiments. Regression analysis was performed by GraphPad Prism 7 software. See figure legends for details. Figure S1 . Characterization of SLERT, Related to Figures 1 and 2 (A) The copy number of SLERT per cell in PA1 and H9 cells. Left, the linear relationship between the log SLERT copy number and its C T value by qRT-PCR. Black dots represent known copies of SLERT from a plasmid DNA containing SLERT sequences and the red and blue dots represent SLERT copies in examined cells. Right, the average copies of SLERT per cell.
Supplemental Figures
(B) The relative abundance of SLERT (red) in PA1 cells. The Ct value of each RNA was shown and the primer sets used to determine each lncRNA were from published studies.
(C) SLERT is highly expressed in a number of human cell lines, revealed by NB with a probe shown in Figure 1A . 28S and 18S rRNA were used as loading controls.
(D) Alternative splicing of tbrg4 pre-mRNA in PA1 cells. Semiquantitative RT-PCR with primers targeting the exons 3 and 6 of TBRG4 showed two major bands in Agarose gel. The longer isoform contains exons 3-6 of TBRG4 and the shorter one contains exons 3 and 6.
(E) The half-lives of the full-length tbrg4 mRNA, the tbrg4 isoform with exons 4 and 5 skipped and SLERT. PA1 cells were treated with 5 mg/ml a-amanitin for different times and the total RNA was extracted and analyzed by qRT-PCR.
(F) Formaldehyde cross-linking RIP of DKC1. The assay was performed in PA1 cells using anti-DKC1 or anti-IgG antibodies followed by qRT-PCR. XIST and one box C/D snoRNA-ended sno-lncRNA were used as controls. The percentage of RIP-enriched RNA relative to input was calculated. N.D., not detected. (G) SLERT localizes to the nucleolus. Co-staining of SLERT (green) and the nucleolar marker protein Nucleolin (red) in CRL-5807 (upper panels), H9 (middle panels) and HeLa cells (bottom panels). Of note, the ISH probe recognizes the internal sequence of SLERT also detects the exon 4 in tbrg4 mRNA ( Figure 1B ). Long exposure time was applied to visualize the low expressed endogenous SLERT in HeLa cells, which resulted in signals of cytoplasmic tbrg4 mRNA (white asterisk).
(H) SLERT KO by CRISPR/CAS9 in PA1 cells. Each sgRNA targets the box H of each snoRNA, the minimal sequence that is required for SLERT formation (see Figure 1D ). Several single clones carrying the indicated deletion in double alleles were identified. (I) SLERT KO led to significantly reduced pre-rRNA production. Total RNA was extracted and analyzed by qRT-PCR. Data were normalized to actin mRNA. (J) The internal sequence of SLERT promoted pre-rRNA transcription. Left, qRT-PCR revealed the relative expression level of the WT-and egfp-SLERT in WT-and egfp-SLERT OE cells. Middle, overexpression of wt-, but not egfp-SLERT, led to increased pre-rRNA production in PA1 cells, as revealed by qRT-PCR. Data were normalized to actin mRNA. Right, overexpression of wt-, but not egfp-SLERT led to increased pre-rRNA production, as revealed by NB. The relative levels of prerRNA were determined using Quantity One and labeled underneath. In (A), (B), (E), (F), (I) , and (J), error bars represent SD in triplicate experiments.
